The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

A well-known US science journal focused on environmental health has stopped accepting new studies, raising alarms among researchers who rely on it heavily.

Daily variation in continuous glucose monitoring metrics was associated with cognitive performance among patients with type 1 diabetes.